Brief: SkinBioTherapeutics Appoints Rachel Parsonage As Interim CEO
02/03/2026 07:40
March 2 (Reuters) - SkinBioTherapeutics PLC SBTX.L: SKINBIOTHERAPEUTICS - APPOINTMENT OF INTERIM CEO SKINBIOTHERAPEUTICS PLC - APPOINTS RACHEL PARSONAGE AS INTERIM CEO Source text: ID:nRSB8127Ua Further company coverage: SBTX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company